Cargando…
Computational Insights into Binding of Bisphosphates to Farnesyl Pyrophosphate Synthase
Bisphosphonates (BPs) are the most widely used and effective treatment for osteoporosis and Paget's disease. Non-nitrogen containing BPs (non-N-BPs), namely etidronate, clodronate, tiludronate, as well as nitrogen-containing BPs (N-BPs), namely pamidronate, alendronate, ibandronate, risedronate...
Autores principales: | Ohno, K, Mori, K, Orita, M, Takeuchi, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343387/ https://www.ncbi.nlm.nih.gov/pubmed/21110804 http://dx.doi.org/10.2174/092986711794088335 |
Ejemplares similares
-
Crystallographic and thermodynamic characterization of phenylaminopyridine bisphosphonates binding to human farnesyl pyrophosphate synthase
por: Park, Jaeok, et al.
Publicado: (2017) -
Structural characterization of substrate and inhibitor binding to farnesyl pyrophosphate synthase from Pseudomonas aeruginosa
por: Schmidberger, Jason W., et al.
Publicado: (2015) -
Human farnesyl pyrophosphate synthase is allosterically inhibited by its own product
por: Park, Jaeok, et al.
Publicado: (2017) -
Molecular Cloning and Characterisation of Farnesyl Pyrophosphate Synthase from Tripterygium wilfordii
por: Zhao, Yu-Jun, et al.
Publicado: (2015) -
Positive selection and functional divergence of farnesyl pyrophosphate synthase genes in plants
por: Qian, Jieying, et al.
Publicado: (2017)